{"id":"636752920377-18","name":"Global Alliance for Tuberculosis Drug Development","registrationDate":"2016-01-20T22:36:12.920+01:00","category":3,"subCategory":2,"legal":"501(c)(3)","web":"http://www.tballiance.org","country":"United states","headAddress":"40 Wall Street","headCity":"New York","headPostCode":"10005","headPhone":"(1)21 22 27 75 40","boss":"Mel Spigelman","bossTitle":"Mr","bossPosition":"President &amp; CEO","membersCount":2,"membersFTE":"0.5","membership":"","memberOrga":"","goal":"TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster-acting, and affordable tuberculosis drugs that are available to those who need them.","acronym":"TB Alliance","interests":"Budget, Public Health, Research and Technology","euInitiatives":"Innovation for global health research and development primarily in Horizon2020 and FP9.","lastUp":"2018-01-16T16:22:40.534+01:00","customers":"","costAbsolu":"","costRange":"10000-24999","turnoverAbsolu":0,"turnoverRange":""}